Navigation Links
iBio Adds New Therapeutic Antibody to Its Pipeline
Date:3/4/2013

eins difficult or impossible to produce with other methods; broad applicability to biologics, including therapeutic proteins and vaccines; production time measured in weeks instead of months or more. Additional benefits may include a surge capacity for remedial action against bioterrorism and pandemic disease including influenza; product entry that is unconstrained by traditional process patents, and significantly lower capital and operating costs for comparable production.

About Influenza

Influenza virus infection is a common infectious disease that often causes mild symptoms but can lead to severe symptoms and death. Influenza epidemics occur yearly, causing three to five million cases of severe illness, and about 250,000 to 500,000 deaths worldwide. Although the common strains of influenza constitute a significant public health concern, more dangerous influenza strains have emerged periodically leading to pandemics that kill millions of people. The high mutation rate of influenza viruses leads to the frequent emergence of new strains and also to the development of resistance to antiviral drugs. An effective antibody-based influenza drug based on iBio technology has the potential to effectively treat such drug-resistant infections as well as complex and advanced infections.

About Antibody Therapeutics

The use of monoclonal antibodies for the treatment of a wide variety of diseases and illnesses has emerged as one of the most important contributions of biotechnology to clinical medicine. A few dozen antibody products generate global annual sales of about $50 billion, and several hundred new product candidates are in clinical trials for many medical applications. Rituximab is an antibody drug approved for treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and other diseases, generating annual sales in excess of $6 billion. Palivizumab is an antibody drug used to prevent serious lung infections caused
'/>"/>

SOURCE iBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
2. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
3. Society for Brain Mapping and Therapeutics endorse President Obamas support for Human Brain Mapping research; nominating him for prestigious Pioneer in Healthcare Policy Award
4. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
5. United Therapeutics Announces Additional $420 Million Share Repurchase Program
6. Juventas Therapeutics Hires Biotechnology Veteran Paul Resnick as Vice President of Business Development
7. Convoy Therapeutics Announces the Relaunch of Their Interactive Website
8. Exon skipping to restore gene expression is promising therapeutic strategy for muscular dystrophy
9. Shield Therapeutics Selects OpenClinica Enterprise
10. Regenetek Research Inc. Launches New Intelligent Software for Therapeutic Stem Cell Trials
11. Cell Therapeutics, Inc.s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 Local veterinarian, Dr. ... Hospital are seeking candidates to participate in an investigational ... The ultimate goal of this study is to ... into one or two arthritically affected joints can help ... , Candidates for the current investigational study must be ...
(Date:8/29/2014)... Due to a misstatement posted by the Family Resource ... Center, LLC ( ASCTC ) was reported as an entity ... benefit ALS patients. Because of ASCTC's exclusive focus on ... therapeutic applications, FRC listed ASCTC as one of several alternatives ... not to support research that requires the death of human ...
(Date:8/29/2014)... August 29, 2014 Intrinsic Imaging, ... certified, GAMP® 5 compliant imaging core lab, announced ... Phase II clinical trial to assess a new ... this trial, Intrinsic Imaging will provide comprehensive imaging ... protocol and charter development, site qualification, site training ...
(Date:8/28/2014)... Nevada City, CA (PRWEB) August 28, 2014 ... and sanitation products for the food processing industry, is ... conducting a side-by side comparison of the E2 soap ... Q E2 Sanitizing Foam Soap . Hand hygiene ... pathogens in the food processing environment. Six key criteria ...
Breaking Biology Technology:Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2
... ATLANTA, May 1 CryoLife, Inc., (NYSE: ... company, announced today,that Harvey Morgan has been elected ... Morgan is a Managing Director at Bentley,Associates L.P., ... more than 35 years of investment banking experience ...
... accelerating market penetration and revenue growth, SCOTTSDALE, ... technology company that markets the Provant(R) Wound Therapy,System, ... as Vice,President of Marketing. Most recently Mr. Robey ... Inc (KCI) for the V.A.C.(R) Therapy,brand, during the ...
... SEATTLE, May 1 Therapies under development to ... growth factor,(IGF-1) to activate its target receptor could ... gene -- p53 -- is already,compromised, according to ... Center., IGF-1 is a polypeptide hormone that ...
Cached Biology Technology:Harvey Morgan Joins CryoLife Board of Directors 2Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing 2New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor 2New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor 3
(Date:8/29/2014)... has been known about what genetic changes transform wild ... one of whom is a University of Montana assistant ... controlling the development of the brain and the nervous ... was published Aug. 28 in Science and ... at http://www.sciencemag.org/ ., The domestication of animals and ...
(Date:8/29/2014)... in German . ... natural nitrogen cycle on Earth and in biological wastewater ... to depend on nitrite as their source of energy. ... a microbiologist at the University of Vienna, has now ... alternative source of energy. The oxidation of hydrogen with ...
(Date:8/29/2014)... Bend them, stretch them, twist them, fold them: modern ... extraordinary technological potential, whether as artificial skin or electronic ... use remains a challenge but a new way of ... could be a game-changer. , Previous success in ... on the use of precious gold and silver nanowires. ...
Breaking Biology News(10 mins):New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Copper shines as flexible conductor 2
... to treat bacterial infections causes a continual and vicious ... and spread of resistant strains, forcing the use of ... what if it doesn,t have to be that way? ... Biochemistry and Molecular Biology,s annual meeting, titled "Driving backwards ...
... We all know that eating a calcium-rich diet is ... concept is clearly on display in any elementary school ... with celebrity icons encouraging children to make sure they ... urging school-aged children to pay attention to their dairy ...
... genes out of action allows researchers to learn what genes ... Utah biologists pioneered the field. Mario Capecchi won a Nobel ... to cripple fruit fly genes. Now, biologist Erik Jorgensen and ... nematode worms. "We developed a method that allows us ...
Cached Biology News:Putting bacterial antibiotic resistance into reverse 2Study suggests a much earlier onset for bone problems 2Study suggests a much earlier onset for bone problems 3Worm genes KO'd 2Worm genes KO'd 3Worm genes KO'd 4Worm genes KO'd 5